Strategic funding Gilde Healthcare is a specialized European healthcare investor managing two funds (lower mid-market buy-out and venture & growth), actively deploying capital across Europe and North America. This suggests opportunities to discuss co-investments, fund-on-fund partnerships, or advisory services aligned with their investment cycles and thesis.

Healthcare platform Recent acquisitions and investments across imaging, neuroimaging, vascular therapies, and medtech indicate a growth strategy focused on innovative healthcare technologies. Engage with portfolio companies or Gilde’s deal teams to present disruptive medtech, diagnostics, digital health, and therapeutics solutions with scale potential.

Tech-enabled Gilde’s portfolio and activity show tech-forward investment behavior (digital health, imaging, and clinical tech). There are opportunities to offer healthtech software, data analytics, regulatory compliance tooling, or AI-enabled decision support that can enhance portfolio company outcomes or due diligence processes.

Climate & impact Launch of the Climate Solutions fund signals emphasis on sustainability-aligned investments. Propose environmental, social, and governance (ESG) consulting, decarbonization strategies, or climate-positive healthcare solutions as value-add services to attract them as a partner or co-investor.

Global reach Portfolio activity spans Europe and North America with high-profile financings (Endovascular Engineering, Okami Medical, NIRx, Artinis). This opens doors for cross-border distribution partnerships, regulatory navigation support, and international market entry services tailored to medtech and digital health companies seeking expansion.